APA

Nevill T. J., Hogge D. E., Toze C. L., Nantel S. H., Power M. M., Abou Mourad Y. R., Song K. W., Lavoie J. C., Forrest D. L., Barnett M. J., Shepherd J. D., Nitta J. Y., Wong S., Sutherland H. J. & Smith C. A. (20090107). Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML. : Bone marrow transplantation.

Chicago

Nevill T J, Hogge D E, Toze C L, Nantel S H, Power M M, Abou Mourad Y R, Song K W, Lavoie J C, Forrest D L, Barnett M J, Shepherd J D, Nitta J Y, Wong S, Sutherland H J and Smith C A. 20090107. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML. : Bone marrow transplantation.

Harvard

Nevill T. J., Hogge D. E., Toze C. L., Nantel S. H., Power M. M., Abou Mourad Y. R., Song K. W., Lavoie J. C., Forrest D. L., Barnett M. J., Shepherd J. D., Nitta J. Y., Wong S., Sutherland H. J. and Smith C. A. (20090107). Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML. : Bone marrow transplantation.

MLA

Nevill T J, Hogge D E, Toze C L, Nantel S H, Power M M, Abou Mourad Y R, Song K W, Lavoie J C, Forrest D L, Barnett M J, Shepherd J D, Nitta J Y, Wong S, Sutherland H J and Smith C A. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML. : Bone marrow transplantation. 20090107.